Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 White Lale Director Grant or award · Stock Options +40,565 199,246
2025-06-26 White Lale Director Grant or award · Stock Options +40,565 158,681
2024-06-27 White Lale Director Grant or award · Stock Options +29,700 146,974
2023-06-15 White Lale Director Grant or award · Stock Options +27,700 117,274
2022-09-19 White Lale Director Purchase +15,000 $1.64 $25K 113,788
2022-07-05 White Lale Director Option exercise +28,858 $2.60 $75K 98,788
2022-07-05 White Lale Director Option exercise · Stock Options −28,858 $2.60 $75K 60,716
2022-03-09 White Lale Director Grant or award · Stock Options +26,800 89,574
2021-06-10 White Lale Director Grant or award · Stock Options +22,000 62,774
2020-06-17 White Lale Director Grant or award · Stock Options +28,858 40,774
2020-05-14 White Lale Director Purchase +69,930 $1.43 $100K 69,930
2020-04-16 White Lale Director Grant or award · Stock Options +11,916 11,916

Page 1 of 1 · 12 trades